Volume 20, Issue 10 (January 2023)                   Nursing and Midwifery Journal 2023, 20(10): 777-785 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Baghaei R, Sorayya H, Alinejad V, Torabzadeh A. بررسی فراوانی و تنوع تداخلات دارویی در بخش‌های مراقبت ویژه مراکز آموزشی درمانی دانشگاه علوم پزشکی ارومیه در سال‌ 1400. Nursing and Midwifery Journal 2023; 20 (10) :777-785
URL: http://unmf.umsu.ac.ir/article-1-4808-en.html
1- Professor of Nursing, Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
2- Associate Professor of pharmacology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran
3- Assistant Professor of Biostatistics. Urmia University of Medical Sciences, Urmia, Iran
4- Masters Student of nursing, School of nursing and midwifery, Urmia University of Medical Sciences, Urmia, Iran(Corresponding Author) , a.torabzadeh74@gmail.com
Abstract:   (1438 Views)

Background & Aim: Drug interactions can cause adverse reactions in the patient, from treatment inefficiency to serious treatment complications. Due to the complexity of drug therapy and the use of several drugs and different drug groups, patients hospitalized in special care units are exposed to more drug interactions. Therefore, the present study was conducted to investigate the frequency of drug interactions in patients admitted to the intensive care unit.
Materials & Methods: This study investigated the medical records of 300 patients admitted to intensive care units of Urmia teaching hospitals. Drug interactions were determined using the Lexi-comp application and Drug Interaction Facts textbook. Statistical analysis was performed using SPSS software v. 16.0.
Result: Of the 300 cases, 138 (%43.3) were male and 160 (%53.7) were female. Two hundred and thirty-one patients (77%) had moderate interaction, 94 patients (%31.3) had mild interaction, and 67 patients (%22.3) had severe interaction. One hundred eighty-six patients had pharmacokinetic interactions, and 201 patients had pharmacokinetic interactions. The most common interaction was for drugs Heparin + Aspirin, with 58 cases.
Conclusion: By making medical personnel aware of the potential side effects of drug interactions and the science of interference, as well as replacing interfering drugs with other drugs as much as possible, paying attention to drugs that frequently cause interference with other drugs, and using interference detection softwares, it is possible to effectively prevent drug interactions and complications in the intensive care unit.
Full-Text [PDF 465 kb]   (633 Downloads)    
Type of Study: Research | Subject: متفرقه

References
1. Yavari F. Patient's Safety and the Human Rights System. J Med Law. 2011;5(18): 117-31. (Persian) [Google Scholar]
2. Cuperus-Bosma JM, Wagner C, van der Wal G. Patient safety in hospitals. Int J Risk Safety Med 2006;18(1):59-64.
3. Donaldson LJ, Kelley ET, Dhingra-Kumar N, Kieny MP, Sheikh A. Medication without Harm: Who's Third Global Patient Safety Challenge. Lancet 2017;389(10080):1680-1. [DOI:10.1016/S0140-6736(17)31047-4] [PMID]
4. Stetina P, Groves M, Pafford L. Managingmedication errors-a qualitative study. Med Surg Nurs 2005;14(3):174-8. [Google Scholar]
5. Kalra J, Kopargaonkar A. Quality Care and Patient Safety: Strategies to Disclose Medical Errors. InAdvances in Human Factors and Ergonomics in Healthcare and Medical Devices: Proceedings of the AHFE 2017 International Conferences on Human Factors and Ergonomics in Healthcare and Medical Devices, July 17-21, 2017, The Westin Bonaventure Hotel, Los Angeles, California, USA 8 2018 (pp. 159-167). Springer International Publishing. [Google Scholar]
6. Nash, D. and N. Goldfarb, The Quality Solution: The Stakeholders Guide to Improving Health Care. st Edition, Jones & Bartlett Publishers, 2000 [URL]
7. Shehab N, Lovegrove MC, Geller AI, Rose KO Weidle NJ, Budnitz DS. US Emergency Departmen, visits for outpatient adverse drug events, 2013-2014. JAMA 2016;316(20):2115-25. [DOI:10.1001/jama.2016.16201] [PMID] [PMCID]
8. Shehab N, Lovegrove MC, Geller AI, Rose KO Weidle NJ, Budnitz DS. US Emergency Departmen, visits for outpatient adverse drug events, 2013-2014. JAMA 2016;316(20):2115-25 [DOI:10.1001/jama.2016.16201] [PMID] [PMCID]
9. Karthikeyan M, Lalitha D. A prospective observational study of medication errors in general medicine department in a tertiary care hospital. Drug Metabol Drug Interact 2013;28(1):13-2 [DOI:10.1515/dmdi-2012-0032] [PMID]
10. Afra MG, Aliha JM, Hamooleh MM, Afra LG, Haghani S. Medication errors in intensive care units in the viewpoint of nurses: A descriptive study. Iran J Nurs 2019;1:13-32. [DOI:10.29252/ijn.32.121.1]
11. Hammes JA, Pfuetzenreiter F, Silveira F, KoenigA, Westphal GA. Potential drug interactions prevalence in intensive care units. Rev Bras TerIntensiva 2008;20(4):349-54. [DOI:10.1590/S0103-507X2008000400006]
12. Murtaza G, Khan MY, Azhar S, Khan SA, Khan TM. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J 2015;24(2):220-5. [DOI:10.1016/j.jsps.2015.03.009] [PMID] [PMCID]
13. Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. Australas Med J 2011;4(1):9-14. [DOI:10.4066/AMJ.2011.450] [PMID] [PMCID]
14. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Safety 2007;30(5):379-407. [DOI:10.2165/00002018-200730050-00003] [PMID]
15. Rahimi B, Gharabaghi N, Hesari Z, Balanji S, Alinia T.Prevalence of potential drug interactions in patients in the intensive care unit of urmia taleghani hospital. Stud Med Sci 2013;24(2):135-6. [Google Scholar]
16. Kashefi P, Mousavi S, Hosseini A. The Frequency of Drug Interactions in Patients in the Intensive Care Units of Alzahra Hospital, Isfahan, Iran. J Isfahan Med Sch 2017;35(440):905-10. [Google Scholar]
17. Torkashvand M, Esnaashari F, Mehrpoya M, Fariba F, Nadi F, Zeraati F. Evaluation of Potential Drug Interactions and Related Factors in Patients Admitted in Department of Cardiology of Farshchian Heart Hospital of Hamadan. Avicenna J Clin Med 2018; 25(2):105-111 [DOI:10.21859/ajcm.25.2.105]
18. Asgari M, soleymani M.Intensive care unit in ICU, CCU, dialysis. 3th ed. Tehran. Boshra Publition, 2014;1-9. [URL]
19. Reis A, Cassiani S. Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clinics (Sao Paulo) 2011;66(1):9-15. [DOI:10.1590/S1807-59322011000100003] [PMID] [PMCID]
20. Lima F E, Cassiani S H. Potential drug interaction in intensive care patients at a teaching hospital. RevLatino-am Enfermagem. 2009;17:222-7. [DOI:10.1590/S0104-11692009000200013] [PMID]
21. Jankovic SM, Pejcic AV, Milosavljevic MN, Opancina VD, Pesic NV, Nedeljkovic TT, et al. Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit Care 2018;43:1-6 [DOI:10.1016/j.jcrc.2017.08.021] [PMID]
22. Abideen S, VIVEKANANDAN K, MISHRA P. Assessment of prevalence of potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in India. Assessment 2015;8(1). [Google Scholar]
23. Rodrigues AT, Stahlschmidt R, Granja S, Falcao ALE, Moriel P, Mazzola PG. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy. Saudi Pharm J 2015;23(4):366-70. [DOI:10.1016/j.jsps.2014.11.014] [PMID] [PMCID]
24. Ismail M, Noor S. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study. BMC Health Serv Res 2018;18:762 [DOI:10.1186/s12913-018-3579-7] [PMID] [PMCID]
25. Acharya S, Ragam AS, Holla R, Bhat ARAY. Prevalence of Potential Drug-Drug Interactions in the Intensive Care Unit of a Tertiary Care Hospital: A Cross-Sectional Study. J Young Pharm 2019;11(2):197-201 [DOI:10.5530/jyp.2019.11.41]
26. Hosseini E, Shojaei L, Karimpour H, Shahbazi F. Potential Drug-Drug Interactions in Critically Ill [URL]
27. Eishi A,Valizadeh A ,badavi S.Evaluation of Drug-Drug Interactions in Cancer Patients Admitted to ICU of Imam khomeiny Hospital Urmia. Stud Med Sci 2017;28(3). [Google Scholar]
28. Murtaza G, Khan MY, Azhar S, Khan SA, Khan TM. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J 2015;24(2):220-5 [DOI:10.1016/j.jsps.2015.03.009] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Nursing And Midwifery Journal

Designed & Developed by : Yektaweb